How Has the Antimicrobial Resistance Surveillance Market Evolved Historically and What is its Current Size?
The antimicrobial resistance surveillance market has seen considerable growth due to a variety of factors.
• The market size for antimicrobial resistance surveillance has significantly expanded over recent years. Projected growth from $6.77 billion in 2024 to $7.36 billion in 2025, at a compound annual growth rate (CAGR) of 8.7%, can be seen.
The historical growth has been driven by factors such as the widespread use of antibiotics in agriculture, overprescribing antibiotics in healthcare, scarcity of diagnostic testing, poor measures in infection prevention and control, and global travel and trade.
What is the Forecasted Market Size and CAGR for the Antimicrobial Resistance Surveillance Market?
The antimicrobial resistance surveillance market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to witness robust expansion in the ensuing years, the antimicrobial resistance surveillance market is projected to reach a value of $10.18 billion by 2029, representing a compound annual growth rate (CAGR) of 8.5%.
Key drivers promoting growth throughout the forecast timeline include heightened awareness regarding antimicrobial resistance, progressive diagnostic technical advancements, increased governmental initiatives and funding injections, growth in healthcare-associated infection cases, and introduction of fresh antibiotics and alternatives. Forefront trends likely to shape the market during the forecast period encompass utilization of artificial intelligence in data analysis, emergence of next-generation sequencing technologies, real-time monitoring systems, molecular diagnostic instruments, and the convergence of big data with machine learning to facilitate predictive modeling.
What Main Forces Are Fueling Expansion In The Antimicrobial Resistance Surveillance Market?
The growth of the antimicrobial resistance surveillance market is expected to be fueled by the escalating prevalence of infectious diseases. These diseases, caused by harmful microorganisms such as bacteria, fungi, viruses, or parasites, can transmit directly or indirectly between individuals. The surge in infectious diseases can be linked to factors like climate change, urbanization, and worldwide travel, which can intensify the spread of pathogens and expose humans to new microbes. Antimicrobial resistance surveillance plays a crucial role in monitoring the distribution of resilient pathogens, enabling effective treatment plans and shaping public health policies to fight infectious diseases. For instance, a report from the UK Health Security Agency unveiled in February 2024 disclosed a 10.7% rise in tuberculosis (TB) cases in England, equating to 4,850 cases in 2023 compared to 4,380 in 2022. Consequently, the rising prevalence of infectious diseases fuels the expansion of the antimicrobial resistance surveillance market.
What Are The Market Segments In The Antimicrobial Resistance Surveillance Market?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
Pre-Book The Antimicrobial Resistance Surveillance Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Antimicrobial Resistance Surveillance Market?
Leading firms in the market are directing their efforts towards the development of innovative technologies, like novel diagnostic tools, with an aim to optimize existing processes, increase overall efficiency, and deliver superior results for both patients and end-users. Diagnostic tools can include equipment, devices, software, or techniques that are utilized to identify or ascertain the existence of a medical condition, disease, or problem. For example, Sysmex Astrego AB, a company based in Sweden that manufactures and provides service for diagnostic products, unveiled the PA-100 AST Point-of-Care Testing System in June 2023. The newly launched system offers quick and precise detection of antimicrobial resistance at the point of care, marking a substantial decrease in time, compared to the conventional laboratory methods which can span several days. It provides results within 30 minutes, thereby enabling healthcare providers to decide on an effective course of treatment for infections in a timely manner. This in turn, lowers the dependence on broad-spectrum antibiotics, assisting in the fight against the spread of antimicrobial resistance.
Who Are the Key Players In The Antimicrobial Resistance Surveillance Market?
Major companies operating in the antimicrobial resistance surveillance market are:
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Becton
• Dickinson and Company
• Viatris Inc.
• Wolters Kluwer NV
• Hologic Inc.
• Biomerieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen NV
• Cepheid Inc.
• Shionogi & Co. Ltd.
• Venatorx Pharmaceuticals Inc.
• Accelerate Diagnostics Inc.
• Paratek Pharmaceuticals Inc.
• Liofilchem Srl
• Lumed Inc.
• OpGen Inc.
What Are The Regional Insights Into The Antimicrobial Resistance Surveillance Market?
North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
